Dr. Nebasi Valantine, MD

Dr. Valantine practices at Allina Health Coon Rapids Clinic in Minneapolis, Minnesota.

Dr. Valantine's NPI, 1134623721, was assigned on March 20, 2018. Dr. Valantine holds Wisconsin license 75849-02.

Dr. Valantine's primary practice is Allina Health Coon Rapids Clinic, at 9055 Springbrook NW Dr, Minneapolis, MN 55433 in Anoka County. The practice phone is (763) 780-9155.

Dr. Valantine's primary practice is Allina Health Coon Rapids Clinic in Minneapolis, Minnesota. Dr. Valantine is also affiliated with Abbott Northwestern Hospital. The medical group on file is Buffalo Hospital. Dmand AI also links Dr. Valantine to 2 more hospitals and 2 home health agencies, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Valantine practices, 5 sites in all. Vendor and product names are available with a free account.

Family medicine is Dr. Valantine's primary specialty in the NPI Registry, under taxonomy code 207Q00000X. Dmand AI has Dr. Valantine's licenses on file in 2 states: Wisconsin and Ohio.

CMS data shows 551 Medicare services from Dr. Valantine across 8 procedure codes in 2024, for 237 Medicare patients. Medicare paid $38,327 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 237 Medicare patients who saw Dr. Valantine in 2024. The largest group is 65 to 74, with 137 patients. 75% of them have high cholesterol, and 70% have high blood pressure. 10% are also on Medicaid. Their average risk score is 1.08, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Valantine's median patient age at 62, with 30% women.

In 2024, Dr. Valantine wrote 8,529 Medicare Part D claims for 630 patients. 90% of them were for generic drugs. CMS names the drug for 7,899 of them, across 136 drugs with 11 or more claims each, at $525,245 in total drug cost. In 2023, CMS named 5,294 claims across 105 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Valantine for performance year 2024, reported as part of a group. Dr. Valantine accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Valantine as offering telehealth.

CMS Open Payments shows 10 general payments to Dr. Valantine from 3 drug and device companies from 2021 to 2024. Food and beverage make up the largest share, 100% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $391.